Christopher Mitromaras, MD
Vascular Surgery · Concord, NCNPI 1801104971
Payments from drug & device makers
What this record shows
It is spread thinly across 30 manufacturers, the largest accounting for just 23.8%. Reporting peaked in 2024 at $2,948 and has fallen 53.1% since, to $1,382 in 2025.
Across 142 payments — averaging $73.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Penumbra, Inc.$1K
- Bard Peripheral Vascular, Inc.$1K
- W. L. Gore & Associates, Inc.$1K
- Silk Road Medical, Inc.$922
- Medtronic$640
- plus $3K from 24 others
What the payments were for
- Travel & lodging$4,68245%
- Food & beverage$5,79355%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 10 | $2,494 |
| Penumbra, Inc. | 7 | $1,456 |
| Bard Peripheral Vascular, Inc. | 34 | $1,332 |
| W. L. Gore & Associates, Inc. | 5 | $1,032 |
| Silk Road Medical, Inc. | 12 | $922 |
| Medtronic(2 entities) | 8 | $640 |
| Cook Medical LLC | 9 | $470 |
| Johnson & Johnson | 21 | $426 |
| Endologix LLC | 4 | $397 |
| Philips North America LLC | 6 | $256 |
| Stryker | 3 | $208 |
| Inari Medical, Inc. | 3 | $160 |
| Getinge USA Sales, LLC | 1 | $113 |
| Sonavex, Inc. | 1 | $91 |
| Cvrx, Inc. | 1 | $77 |
| Imperative Care, Inc | 2 | $68 |
| Edwards Lifesciences | 2 | $64 |
| Abiomed | 1 | $45 |
| Shockwave Medical, Inc | 1 | $28 |
| Shape Memory Medical Inc. | 1 | $25 |
| Convatec Inc. | 1 | $23 |
| Abbott | 1 | $23 |
| Terumo Medical Corporation | 1 | $21 |
| Angiodynamics, Inc. | 1 | $20 |
| Acera Surgical, Inc. | 1 | $17 |
| Bolton Medical Inc | 1 | $16 |
| Siemens Medical Solutions USA, Inc. | 1 | $14 |
| Avinger Inc. | 1 | $13 |
| Cardiovascular Systems Inc. | 1 | $12 |
| Teleflex LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EKOSONIC$2,118
- RUBY Coil$1,221
- ENROUTE Transcarotid Neuroprotection System$751
- ENROUTE Transcarotid Stent System$751
- ENHANCE Transcarotid Peripheral Access Kit$751
- ENROUTE 0.014 Guidewire$751
- GORE TAG Thoracic Endoprosthesis$495
- GORE TAG Thoracic Branch Endoprosthesis$342
- AFX2 Bifurcated Endograft System$175
- Ovation iX Iliac Stent Graft$175
- Torus Stent Graft System$170
- ENDOCROSS Device$170
- FlowTriever$164
- ENDURANT IIS$158
- GENERAL ANGIOGRAPHY$150
- Zenith Spiral-Z$147
- ELUVIA$147
- (BR5) Peripheral IVUS$144
- Zenith Alpha$141
- GORE VIABAHN Endoprosthesis with Heparin$139
How this compares
$10,475 in reported general payments places this provider in the 75th percentile of 119 vascular surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 22 | $21,993 |
| EliquisApixaban | 16 | $12,899 |
| ClopidogrelClopidogrel Bisulfate | 93 | $789 |
| Gabapentin | 15 | $294 |
| Atorvastatin Calcium | 43 | $250 |
| Rosuvastatin Calcium | 23 | $125 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $426 | $21,99322 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 119 vascular surgery providers in North Carolina.
Other vascular surgery in Concord
- Frank ArkoCharlotte$2.6M
- Erin MurphyCharlotte$598K
- Robert MendesRaleigh$408K
- Ellen DillavouRaleigh$284K
- Mark FarberChapel Hill$245K
- Hector Crespo SotoCharlotte$178K
- Rebecca KelsoCharlotte$148K
- William MarstonChapel Hill$83K
- Bryan EhlertGoldsboro$83K
- Christopher McQuinnRaleigh$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.